Scientists have recently claimed to have found a cure for MRSA, the well-known but dangerous cause of harmful skin infection, after finding medications on a computer database that were originally thought to have no association to treat it.

These findings show that patients may be able to find routine treatment for infections caused by MRSA within two to three years. The drug is well known for its use in the treatment of illness, as well as its safety for use.

Most attempts to control MRSA haven’t succeeded much in the past few years, but recent discoveries are beginning to show that the “bug” can be controlled.

Professor Malcolm Young has developed ways to speed up the search for a cure, and used different ways to identify protein combinations that are needed to kill MRSA. He also tests other antibiotics to tell whether or not they have the potential of killing MRSA in most conventional 10m compounds.

The drug, ETS 1153,  is currently used for treatment of other illness, but is considered a good candidate for treating MRSA.

Professor Malcolm Young stated that “we can bypass some of the early testing because they’ve been through the clinical trials process before and we know they’re safe. We should have them in hospitals in two to three years.”

ETS 1153 shows under laboratory study to have killed all 50 strains of MRSA that it was tested on, even strains that are resistant to Vancomycin.